Literature DB >> 10940592

Alterations in the reproduction of mice induced by rapanone.

J Calle1, J Olarte, R Pinzon, L F Ospina, M C Mendoza, M J Orozco.   

Abstract

Oral administration of rapanone to a group of female mice at doses of 60 and 120 mg/kg, reduced the percentage of pregnancies compared to control group, suggesting an anovulatory effect. Postcoital administration induced uterine alteration in both the first and second gestation periods. These results seem to indicate inhibition of trophoblast implantation in the first period, and an abortive effect and/or reabsorption in the second. Daily administration of rapanone to a group of male mice resulted in fertility alteration, which is attributed to an antispermatogenic effect. Rapanone did not show acute toxic effects at the doses tested in this research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940592     DOI: 10.1016/s0378-8741(99)00214-7

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  3 in total

1.  Effects of the oral administration of nonpolar extract from Ardisia squamulosa Presl (Myrsinaceae) leaves on spermatogenesis in rats.

Authors:  Dennis D Raga; Glorina N Pocsidio; Annabelle A Herrera
Journal:  Pharmacognosy Res       Date:  2011-10

2.  Antimicrobial Potential of Essential Oils from Cerrado Plants against Multidrug-Resistant Foodborne Microorganisms.

Authors:  Genilson Silva de Jesus; Ana Camila Micheletti; Rafael Gonçalves Padilha; Jessica de Souza de Paula; Flavio Macedo Alves; Cassia Rejane Brito Leal; Fernanda Rodrigues Garcez; Walmir Silva Garcez; Nidia Cristiane Yoshida
Journal:  Molecules       Date:  2020-07-21       Impact factor: 4.411

Review 3.  Heliotropium indicum L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.

Authors:  Chandan Sarkar; Milon Mondal; Bilkis Khanom; Md Monir Hossain; Md Solayman Hossain; Antoni Sureda; Muhammad Torequl Islam; Miquel Martorell; Manoj Kumar; Javad Sharifi-Rad; Ahmed Al-Harrasi; Ahmed Al-Rawahi
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.